The biopharmaceutical company Biomunex Pharmaceuticals announces the appointment of Dr Simon Plyte as Chief Scientific Officer (CSO) and as a member of its scientific advisory board.
ADVERTISEMENT
ADVERTISEMENT
Log in here to read the desired article.
ADVERTISEMENT
The biopharmaceutical company Biomunex Pharmaceuticals announces the appointment of Dr Simon Plyte as Chief Scientific Officer (CSO) and as a member of its scientific advisory board.